Revance Therapeutics (RVNC)
NASDAQ:RVNC

Revance Therapeutics (RVNC) Similar Stocks

578 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Revance Therapeutics
$379.67M
-1.00
-84.16%
6 Buy
2 Hold
0 Sell
Strong Buy
$12.00
Evolus
$748.82M
-11.44
61.40%
5 Buy
0 Hold
0 Sell
Strong Buy
$21.67
BioMarin Pharmaceutical
$15.97B
78.70
-3.80%
12 Buy
7 Hold
0 Sell
Moderate Buy
$105.82
Crispr Therapeutics AG
$4.63B
-20.04
-3.82%
9 Buy
6 Hold
1 Sell
Moderate Buy
$78.36
ACADIA Pharmaceuticals
$2.93B
-1,130.57
-40.87%
12 Buy
4 Hold
0 Sell
Strong Buy
$27.88

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
RVNC
Revance Therapeutics
3.64
-18.98
-83.91%
EOLS
Evolus
11.96
4.47
59.68%
BMRN
BioMarin Pharmaceutical
84.09
-3.74
-4.26%
CRSP
Crispr Therapeutics AG
54.56
-0.88
-1.59%
ACAD
ACADIA Pharmaceuticals
17.75
-11.85
-40.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis